Precigen (PGEN) Asset Writedowns and Impairment (2014 - 2024)

Precigen (PGEN) has 11 years of Asset Writedowns and Impairment data on file, last reported at $32.9 million in Q2 2024.

• Asset Writedowns and Impairment for Q2 2024 came in at $32.9 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $32.9 million (down 1.33% YoY), and the FY2024 annual result was $32.9 million, up 7296.63% from the prior year.
• Asset Writedowns and Impairment climbed to $32.9 million in Q2 2024 per PGEN's latest filing, from $445000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $32.9 million in Q2 2024 and troughed at $49000.0 in Q4 2021.
• A 5-year average of $4.1 million and a median of $484000.0 in 2020 frame the typical range for Asset Writedowns and Impairment.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 717.19% in 2020 and fell as far as 99.56% in 2020.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $140000.0 in 2020, then slumped by 65.0% to $49000.0 in 2021, then jumped by 524.49% to $306000.0 in 2022, then soared by 45.42% to $445000.0 in 2023, then jumped by 7296.63% to $32.9 million in 2024.
• Business Quant data shows PGEN's Asset Writedowns and Impairment at $32.9 million in Q2 2024, $445000.0 in Q4 2023, and $306000.0 in Q4 2022.